We are live on ! Find out more

Micro Cap Healthcare
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
GANX icon
151
Gain Therapeutics
GANX
$78.5M
$78.5M $1.84 12.9%
ENLV icon
152
Enlivex Ltd
ENLV
$78.1M
$78.1M $4.73 1.94%
RANI icon
153
Rani Therapeutics
RANI
$77.7M
$77.7M $0.6910 0.68%
RNTX
154
Rein Therapeutics
RNTX
$76.5M
$76.5M $0.8948 6.02%
DH icon
155
Definitive Healthcare
DH
$76M
$76M $0.7251 0.65%
GOSS icon
156
Gossamer Bio
GOSS
$75.7M
$75.7M $0.1548 9.79%
OKYO
157
OKYO Pharma
OKYO
$75.6M
$75.6M $1.44 5.11%
BTMD icon
158
Biote Corp
BTMD
$75.5M
$75.5M $2.52 1.2%
OM icon
159
Outset Medical
OM
$75.3M
$75.3M $4.12 1.48%
NNOX icon
160
Nano X Imaging
NNOX
$75.2M
$75.2M $1.08 2.7%
ACRV icon
161
Acrivon Therapeutics
ACRV
$74.9M
$74.9M $1.75 0.57%
ATRA icon
162
Atara Biotherapeutics
ATRA
$74.7M
$74.7M $8.63 4.1%
TELO icon
163
Telomir Pharmaceuticals
TELO
$74.3M
$74.3M $1.08 17.5%
ACET icon
164
Adicet Bio
ACET
$73.8M
$73.8M $8.12 2.92%
ANVS icon
165
Annovis Bio
ANVS
$71.9M
$71.9M $1.75 3.55%
PYPD icon
166
PolyPid
PYPD
$71.7M
$71.7M $3.74 27.4%
LONA
167
LeonaBio Inc
LONA
$71.1M
$71.1M $7.98 5.42%
LNSR icon
168
LENSAR
LNSR
$70.6M
$70.6M $5.76 0.17%
OSTX
169
OS Therapies Inc
OSTX
$69.5M
$69.5M $1.56 3.31%
XBIT icon
170
XBiotech
XBIT
$68.6M
$68.6M $2.24 0.44%
PMVP icon
171
PMV Pharmaceuticals
PMVP
$68.3M
$68.3M $1.31 2.34%
HYFT
172
MindWalk Holdings
HYFT
$68.2M
$68.2M $1.46 2.1%
IBIO icon
173
iBio
IBIO
$68.1M
$68.1M $1.41 2.92%
PLRX icon
174
Pliant Therapeutics
PLRX
$67.5M
$67.5M $1.09 1.87%
TLPH icon
175
Talphera
TLPH
$67M
$67M $1.31 1.55%
5 6
7
8 9

Micro Cap Healthcare Stocks at a Glance

Healthcare companies develop drugs, build medical devices, run hospitals and insurers, and supply the systems behind patient care. Demand is largely non-discretionary, but returns hinge on drug-pipeline outcomes, patent lives, and reimbursement policy — a mix of defensive services and high-risk, high-reward research bets.

There are 492 micro cap Healthcare stocks — companies in the Healthcare sector with a market cap under $250M — worth a combined $31.5B.

The largest by market cap are Profound Medical (PROF) at $247M, Entrada Therapeutics (TRDA) at $246M and Fulcrum Therapeutics (FULC) at $245M.

Among institutional investors, Atrium Therapeutics (RNA) drew the most net new fund positions in Q1 2026: 162 funds opened new positions.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q1 2026.